FDA selects Ingenix fpr drug safety monitoring and support New Technology to Help Accelerate Identification of Drug Safety Signals
04 Oct 2005 -
Ingenix, a wholly owned subsidiary of UnitedHealth Group has been selected by the United States Food and Drug Administration (FDA) to help improve the effectiveness and speed of safety evaluations for pharmaceutical agents. The Ingenix program is built around a team of leading epidemiologists, complex analytic tools, and the largest and most complete longitudinal patient database available today.
It will work with the FDA to monitor the safety of new drugs as well as conduct ad hoc safety studies on established pharmaceutical agents.
Additional information
i3 Research Basking Ridge, NJ, United States of America
Top
Contact
Print version
PDF version
Send article
RSS-Feed